U.S. Banks Stock News

Argan (AGX) closed out FY 2026 with fourth quarter revenue of US$262.1 million and basic EPS of US$3.54, capping a year in which trailing twelve month revenue reached US$944.6 million and EPS came in at US$10.00. Over recent periods the company has seen quarterly revenue shift between US$193.7 million and US$262.1 million, with basic EPS ranging from US$1.65 to US$3.54 as earnings growth of 61.2% over the past year and a higher net profit margin of 14.6% set the tone for this latest update...

ACI Worldwide (NasdaqGS:ACIW) released its latest Tax Payment Trends report, highlighting a generational shift in tax filing and payment behaviors. The research points to a substantial portion of Gen Z not engaging in federal tax filing and underscores a widening digital divide in how consumers handle taxes. The report provides new insight into consumer expectations around digital payments and financial interactions, with potential implications for tax authorities and payment providers. ACI...

Marriott International (NasdaqGS:MAR) receives 2026 Platinum Employer recognition on the Where You Work Matters List, reportedly as the only hotel company on the list. The company confirms the reopening and renovation of the ARC Hotel in Washington DC as part of the Series by Marriott brand. The developments highlight Marriott's focus on workplace opportunity and its Series by Marriott offering for experience driven and urban travelers. For investors following NasdaqGS:MAR, these updates...

Harley-Davidson (HOG) has moved back into focus after announcing global workforce reductions and outlining plans to tackle weaker demand, higher tariff costs, and recent revenue and profit declines. See our latest analysis for Harley-Davidson. Harley-Davidson’s recent workforce cuts and weaker results have come alongside a 7-day share price return of 10.75%. However, the 1-year total shareholder return of 20.05% and 5-year total shareholder return of 45.95% show longer term momentum has...

Definium Therapeutics (DFTX) is back in focus after recent communications around its April Investor & Analyst Day, where management plans to spotlight late stage DT120 ODT data timelines in major depressive disorder and generalized anxiety disorder. See our latest analysis for Definium Therapeutics. Definium Therapeutics’ recent Investor & Analyst Day spotlight and earlier name change have arrived after a strong run, with a 90 day share price return of 36.91% and a very large 3 year total...

Navan (NAVN) is back in focus after its latest earnings report, where strong Q4 and full year revenue, earlier than planned free cash flow positivity, and AI driven products like Navan Edge caught investor attention. See our latest analysis for Navan. The latest earnings release and upbeat guidance have pulled fresh attention to Navan, even as the share price has been volatile. A 7 day share price return of 37.7% and a year to date share price return decline of 24.9% suggest that short term...

Belden (NYSE:BDC) has been named to Newsweek’s America’s Most Responsible Companies list for a third consecutive year. The company reports achieving key sustainability milestones, including surpassing certain greenhouse gas reduction targets. Belden has expanded its Great Place to Work certification across more global locations. The company plans to introduce new long-term environmental, social, and governance goals in Spring 2026. Belden, listed on the NYSE under the ticker BDC, supplies...

Activist investor Irenic Capital Management has publicly urged Teleflex (NYSE:TFX) to engage with acquisition offers. Irenic is pressing the Board to form a Strategic Review sub committee with new independent directors and consider all options. The investor is also calling for potential board changes, including the appointment of a new Chair, citing concerns about value destruction and leadership gaps. Teleflex, a medical technology company focused on single use devices for critical care...

Wondering if National Fuel Gas at around US$95.29 is still reasonably priced after a strong run, or if you might be turning up late to the story. The stock has returned 3.9% over the past week, 7.7% over the last month, 16.1% year to date, and 24.0% over the past year. This naturally raises questions about how much value is already reflected in the price. Recent coverage has focused on National Fuel Gas as a vertically integrated gas utility and energy company, with attention on how it...

Earlier this week, Truist upgraded Airbnb to Hold from Sell after raising its 2026 adjusted EBITDA and earnings estimates, following Q4 results showing 16% year-over-year Gross Booking Value growth and Q1 2026 revenue guidance of 14%–16% growth. The upgrade underscores how Airbnb’s recent margin pressure was tied to spending on hotel partnerships and new services that Truist now expects to support improved profitability. Next, we’ll examine how Truist’s more optimistic view on Airbnb’s...

Wondering whether Cleveland-Cliffs at a last close of US$8.11 offers value or a value trap? This breakdown will help you frame the price against what the business may be worth. The stock has recently shown mixed performance, with a 3.7% gain over the last 7 days but declines of 24.8% over 30 days, 40.4% year to date, and 4.8% over the past year. These moves sit against a longer track record that shows 55.8% and 58.2% declines over the past 3 and 5 years respectively. This can influence how...

Summit Therapeutics presented new Phase III data on ivonescimab at the 2026 European Lung Cancer Congress in EGFR mutated NSCLC. The data highlighted improved intracranial progression free survival, including in patients with brain metastases. The company has submitted a Biologics License Application to the FDA, with a PDUFA decision date set for November. Summit Therapeutics, trading as NasdaqGM:SMMT, is drawing attention after sharing these late stage results alongside a confirmed FDA...

California Water Service Group (CWT) is back on watch after recent share price moves, with the stock showing mixed returns over the past year as investors reassess this regulated water utility. See our latest analysis for California Water Service Group. At a share price of $45.01, California Water Service Group has recently seen a 7 day share price return of 2.51% but the 1 year total shareholder return is a decline of 4.2%. This suggests that recent momentum contrasts with weaker longer term...

Earlier this month, OpenText released a global report with the Ponemon Institute on managing risks and optimizing the value of AI, generative AI, and agentic AI, highlighting that many enterprises have adopted these tools without fully developed security and governance frameworks. The study’s finding that only a small minority of enterprises fully embed AI into cybersecurity and risk assessment underlines a widening gap between AI deployment and risk management that could influence how...

Markel Group (NYSE:MKL) has appointed Phil Jones as Chief Information Officer, International. Jones brings technology and operational experience across insurance, financial services, and government sectors. The role covers Markel International’s digital capabilities, operational resilience, and service delivery. For investors watching NYSE:MKL, this move highlights the growing importance of technology leadership for insurance and specialty risk businesses. As underwriting, claims, and...

Oklahoma Gas and Electric Company, a subsidiary of OGE Energy (NYSE:OGE), announced a new fixed-income offering of callable senior and subordinated unsecured fixed rate notes. The notes are structured as unsecured obligations and include both senior and subordinated tranches, with fixed interest rates. The securities are callable, meaning the issuer may choose to redeem them before maturity, subject to the offering terms. OGE Energy, through Oklahoma Gas and Electric, operates as a...

Some investors may be considering whether Grindr's current share price reflects its potential value, or whether the market is mispricing the stock at present. Over the past month, Grindr's share price has moved by 11.3%, while the 1 year return shows a 29.8% decline. This may draw the attention of investors who are weighing recent momentum against longer term performance. Recent coverage around Grindr has focused on its position as a listed interactive media and services platform, including...

BridgeBio Pharma has announced that long-term efficacy and safety results from the open-label extension of its Phase 3 ATTRibute-CM trial of acoramidis in ATTR-CM, including multiple analyses on survival, disease stabilization, and patient-reported outcomes, were presented at the American College of Cardiology Annual Scientific Sessions in New Orleans on March 28–30, 2026. The new data, alongside real-world survey findings on treatment patterns and preferences in ATTR-CM, offer a deeper view...

If you are wondering whether Global-E Online is starting to look attractive or still carries too much risk, its recent share price moves and current valuation metrics give you plenty to think about. The stock last closed at US$28.93, with returns of a 10.5% decline over 7 days, a 17.6% decline over 30 days, a 23.6% decline year to date and an 18.9% decline over 1 year. These moves may have shifted how the market is pricing its prospects and risks. These moves have come as Global-E Online...

H.B. Fuller (NYSE:FUL) secured key raw materials after more than 40 force majeure notices linked to Middle East related supply disruptions. The company plans a minimum 10% global price increase effective April 1, 2026, to address inflation and raw material cost pressures. Management has paused acquisitions to focus on debt reduction and share buybacks, which signals a shift in capital allocation priorities. For investors watching NYSE:FUL, the share price sits at $59.17, with a 20.0% gain...

In March 2026, Alteogen announced an exclusive license deal giving Biogen rights to develop subcutaneous formulations for two biologic products using ALT-B4 Hybrozyme technology, while new data from Eisai and Biogen showed strong long-term real-world treatment persistence for intravenous lecanemab in Alzheimer’s patients. Together, these developments highlight Biogen’s push to expand patient-friendly biologic delivery and deepen its presence in Alzheimer’s care through therapies patients are...

Revvity (NYSE:RVTY) plans to hold its annual meeting on April 28, 2026. Shareholders will vote on a proposed bylaw change to let holders of 25% of shares call special meetings. Activist-backed proposals seek tighter executive stock retention requirements tied to equity compensation. Revvity, which operates in life sciences and diagnostics, sits in a sector where governance practices are closely watched, partly because R&D cycles and regulatory oversight can shape capital allocation...

If you are wondering whether eToro Group at around US$29.05 is a bargain or a value trap, this breakdown is designed to help you frame that question clearly. The share price closed at US$29.05, with a 1.3% decline over the past week, a 10.5% decline over the past month, and an 18.6% decline year to date, which may signal shifting views on both risk and potential. Recent coverage has focused on eToro Group as a publicly listed trading platform provider that gives investors access to a wide...

If you are wondering whether Cabot's current share price reflects its true worth, this article breaks down the key valuation clues you can use to judge it for yourself. Cabot recently closed at US$74.11, with returns of 9.3% over the past week, a 2.3% decline over the past month, 10.5% year to date and a 7.7% decline over the past year. Taken together, these figures give mixed signals about how the market is currently pricing the stock. Recent coverage around Cabot has focused on its...